One superior individual will triumph over two; you will obtain it.
Quebec's Life Sciences Industry: A Powerhouse of Economic Growth and Health Innovation
Quebec's life sciences and health technologies (LSHT) industry has a rich historical foundation, a robust current presence, and holds significant potential to impact both the province's economy and healthcare systems.
Historically, Quebec’s industry roots are tied to its knowledge economy development, particularly bolstered during and after the Quiet Revolution in the 1960s, which emphasized francophone participation in scientific and technical careers. The creation and expansion of institutions focused on health and biotechnology, alongside government initiatives, helped drive this sector’s growth.
Currently, the life sciences sector in Quebec is a major economic driver. The biotechnology industry alone includes over 450 companies employing more than 25,000 people and generating $5.6 billion in annual revenues. The health industry, including pharmaceuticals, research, manufacturing, and related fields, comprises 381 companies with over 24,500 employees, featuring the presence of around 20 multinational corporations such as Merck, Pfizer, Novartis, and Johnson & Johnson. Montreal is a significant hub, ranking eighth in North America for pharmaceutical employment. Quebec also hosts critical R&D centers and manufacturing plants of global biotech firms: Moderna has its first plant outside the U.S. in Quebec, while Pfizer’s Canadian headquarters is located in Kirkland, underscoring the province’s strategic importance.
The economic impact is strong, with these industries contributing significantly to Quebec's GDP, reflecting the broader knowledge economy where knowledge sectors represent about 31% of the province's GDP. The thriving pharmaceutical and biotechnology industries not only provide high-value jobs but also stimulate related sectors such as research, education, and advanced manufacturing.
In terms of healthcare impact, Quebec’s life sciences sector supports innovation in treatments and vaccine development, contributing both to local healthcare outcomes and global medical progress. Canadian scientific achievements, including the discovery of insulin and vaccine development for diseases like polio and Ebola, demonstrate a longstanding culture of medical innovation that Quebec companies and institutions continue to build on. The province's firms and research centers play a critical role in advancing therapies for cancer, rare diseases, immunology, and infectious diseases through drug development and biomanufacturing capacity.
Looking ahead, advances in personalized medicine, synthetic biology, and artificial intelligence applied to health open up new horizons. The defense industry in Canada is being relaunched, and biodefense and health security heavily rely on this industry. Our health autonomy depends on our ability to produce and our ability to detect biological threats or global supply chain disruptions and respond quickly.
Supporting life sciences is not just about funding research; it's also about building a complete ecosystem. This ecosystem includes facilitating access to capital, encouraging local industrialization, training specialized labor, and integrating innovation into our healthcare facilities. It is crucial for Quebec to be a welcoming land for health innovation, providing conditions that encourage investment, production, and growth. The socio-economic benefits for Quebec from the life sciences sector are significant, provided it offers support and encouragement commensurate with its ambitions.
Quebec mourns the loss of one of its pioneers in this sector, Francesco Bellini, who co-founded BioChem Pharma and developed Epivir (3TC), a revolutionary antiviral against HIV/AIDS and hepatitis B. Epivir (3TC) is used by millions of patients worldwide. Bellini's legacy continues to inspire the industry, reminding us of the potential for life-changing treatments that can be achieved when the right conditions are in place.
The science and technology advancements in Quebec's life sciences industry have a historical foundation, rooted in the Quiet Revolution and the emphasis on francophone participation in scientific and technical careers.
The health-and-wellness sector in Quebec, particularly the biotechnology industry, is a significant player in the province's economy, employing thousands of people and generating billions in annual revenues.
In the future, the life sciences industry in Quebec will continue to impact both the provincial economy and healthcare systems, with advancements in personalized medicine, synthetic biology, and artificial intelligence applied to health.
